The Latest Breaking News from Opioids

Consulting firm McKinsey and Co. has agreed to pay $78 million to settle claims from insurers and health care funds that its marketing work with Purdue Pharma helped fuel an opioid addiction crisis

Warning that drugs so potent a ‘grain of sand’ dosage can be fatal could spark a US-style drug deaths crisis

Discover the FDA-approved AVERT-D test that determines the risk of opioid use disorder. Exciting but cautious, this test needs further monitoring and clini...

Some $1.5 billion flowed to local government coffers this year, sparking debates about transparency and how to spend the money. Here are 5 takeaways from a year's worth of reporting on the issue.

The House voted to make xylazine a controlled substance, but harm reduction advocates warn this won't help

A major university study is challenging the commonly held view opioids are the most powerful pain relievers.

Vertex solidified its potential for an alternative to opioids in pain treatment, an analyst said Wednesday. VRTX stock broke out.

The US Supreme Court appeared divided on Monday as it heard a challenge to Purdue Pharma's $6 billion opioids settlement immunizing the Sackler family that controlled the drugmaker from future litigation.

The Supreme Court is hearing arguments over a nationwide settlement with OxyContin maker Purdue Pharma that would shield members of the Sackler family who own the company from civil lawsuits over the toll of opioids

The US Supreme Court is to hear a challenge on Monday to Purdue Pharma's $6 billion opioids settlement immunizing the family that controlled the drugmaker from future litigation.

To overcome problematic opioid use, traditional forms of opioid substitution therapy, such as methadone and oral buprenorphine, have become valuable tools. Research shows that patients receiving substitution therapy are more likely to stay in treatment and stop using heroin than patients receiving treatments that do not involve substitutes – such…